Progyny, Inc. (NASDAQ: PGNY) had its price target lowered by analysts at Truist Financial Co. from $46.00 to $37.00. They now have a "buy" rating on the stock.
Progyny, Inc. (NASDAQ: PGNY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $48.00 price target on the stock.
Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024
Progyny (NASDAQ:PGNY) Has More To Do To Multiply In Value Going Forward [Yahoo! Finance]
Progyny, Inc. (NASDAQ: PGNY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $46.00 to $37.00. They now have a "buy" rating on the stock.